Biosimilar Clone Development Service
Product Description
GENEXT GENOMICS PVT LTD
-
IN
-
2024On CPHI since
-
1Certificates
-
1 - 24Employees
Company types
Primary activities
Categories
Specifications
GENEXT GENOMICS PVT LTD
-
IN
-
2024On CPHI since
-
1Certificates
-
1 - 24Employees
Company types
Primary activities
More Products from GENEXT GENOMICS PVT LTD (1)
-
Product Golimumab
Golimumab is a monoclonal antibody that targets and inhibits tumor necrosis factor-alpha (TNF-α), a cytokine involved in inflammatory responses. By blocking TNF-α, golimumab helps reduce inflammation and is primarily used to treat autoimmune diseases such as:
• Rheumatoid arthritis (RA) • Psor...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance